Immunohistochemistry with pancytokeratins improves the sensitivity of sentinel lymph node biopsy in patients with breast carcinoma

Cancer

Volumn 85, Issue 5, 1999, Pages 1098-1103

  Czerniecki, Brian J ^a   Scheff, Alice M ^a   Callans, Linda S ^a   Spitz, Francis R ^a   Bedrosian, Isabelle ^a   Conant, Emily F ^b   Orel, Susan G ^b   Berlin, Jesse ^b   Helsabeck, Cynthia ^a   Fraker, Douglas L ^a   Reynolds, Carol ^c  

^a HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c MAYO CLINIC   (United States)

Author keywords

Breast carcinoma; Immunohistochemistry; Micrometastasis; Sentinel lymph node

Indexed keywords

ADULT; AGED; ARTICLE; BREAST CARCINOMA; CLINICAL ARTICLE; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; LYMPH NODE BIOPSY; LYMPH NODE METASTASIS; METASTASIS POTENTIAL; PRIORITY JOURNAL; RISK ASSESSMENT;

ADULT; AGED; BIOPSY; BREAST NEOPLASMS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; KERATINS; LYMPH NODES; LYMPHATIC METASTASIS; MIDDLE AGED; SENSITIVITY AND SPECIFICITY;

EID: 0032967796     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0142(19990301)85:5<1098::AID-CNCR13>3.0.CO;2-N     Document Type: Article

References (20)

1. Morton D, Wen D, Wong J, Economou S, Cagle L, Storm F, et al. Technical details of intraoperative lymphatic mapping for early stage melanoma. Arch Surg 1992;127: 392-9.
2. Krag D, Meijer S, Weaver D, Loggie B, Harlow S, Tanabe K, et al. Minimal access surgery for staging of malignant melanoma. Arch Surg 1995;130:654-8.
3. Pijpers R, Collet G, Meijer S, Hoekstra O. The impact of dynamic lymphoscintography and gamma probe guidance on sentinel node biopsy in melanoma. Eur J Nucl Med 1995;22:1238-41.
4. Albertini J, Cruse C, Rapaport D, Wells K, Ross M, DeConti R, et al. Intraoperative radiolymphoscintography improves sentinel lymph node identification for patients with melanoma. Ann Surg 1996;223:217-24.
5. Giulano AE, Kirgan DM, Guenther JM, Morton DM. Lymphatic mapping and sentinel lymphadenectomy for breast cancer. Ann Surg 1994;220:391-401.
6. Albertini JJ, Lyman GH, Cox C, Yeatman T, Balducci L, Ku N, et al. Lymphatic mapping and sentinel node biopsy in the patient with breast cancer. JAMA 1996;276: 1818-22.
7. Pijpers R, Meijer S, Hoekstra OS, Collet GJ, Comans EF, Boom RP, et al. Impact of lymphoscintigraphy on sentinel node identification with Technetium-99m-colloidal albumin in breast cancer. J Nucl Med 1996; 38:366-8.
8. Veronesi U, Paganelli G, Galimberti V, Viale G, Zurrida S, Bedoni M, et al. Sentinel-node biopsy to avoid axillary dissection in breast cancer with clinically negative lymph nodes. Lancet 1997;349:1864-7.
9. Giuliano AE, Jones RC, Brennan M, Statman R. Sentinel lymphadenectomy in breast cancer. J Clin Oncol 1997;15: 2345-50.
10. Borgstein P, Meijer S, Pijpers R. Intradermal blue dye to identify sentinel lymph node in breast cancer. Lancet 1997; 349:1668-9.
11. Fisher E, Swamidoss S, Lee C, Rockette H, Redmond C, Fisher B. Detection and significance of occult axillary node metastasis in patients with invasive breast cancer. Cancer 1978;42:2025-31.
12. Rosen P, Saigo P, Braun D, Weathers E, Fracchia A, Kinne D. Axillary micro-and macrometastasis in breast cancer: prognostic significance of tumor size. Ann Surg 1981;194: 585-91.
13. Byrne J, Waldron R, McAvinchey D, Dervan P. The use of monoclonal antibodies for the histopathological detection of mammary axillary micrometastasis. Eur J Surg Oncol 1987;13:409-11.
14. Sedmak D, Meineke T, Knetchgas D, Anderson J. Prognostic significance of cytokeratin positive breast cancer. Mod Pathol 1989;2:516-20.
15. International (Ludwig) Breast Cancer Study Group. Prognostic importance of occult axillary lymph node micrometastasis from breast cancers. Lancet 1990;335: 1565-8.
16. McGuckin M, Cummings M, Walsh M, Hohn B, Bennett I, Wright R. Occult axillary node metastasis in breast cancer: their detection and prognostic significance. Br J Cancer 1996;73:88-95.
17. Gerber B, Krause A, Reimer T. Immunohistochemically detected lymph-node micrometastasis in breast cancer and their correlation with prognostic factors. Breast J 1997;3:106-11.
18. Turner RR, Ollila DW, Krasne DL, Giulano AE. Histopathologic validation of the sentinel lymph node hypothesis for breast carcinoma. Ann Surg 1997;226:271-8.
19. Fisher B, Wolmark N, Redmond C, Deutsch M, Fisher E. Findings from NSABP protocol no. B-04: comparison of radical mastectomy with alternative treatments. II. The clinical and biologic significance of medial-central breast cancers. Cancer 1981;48:1863-72.
20. Cady B. Case against axillary lymphadenectomy for most patients with infiltrating breast cancer. J Surg Oncol 1997; 66:7-10.